Novo Nordisk (NVO) FCF US GAAP (year values) |
|||||||||
2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
FCF | ? | 47 615 000 000 | 47 615 000 000 | 64 134 000 000 | 64 134 000 000 | 70 012 000 000 | 66 027 000 000 | ||
Changes by years, y/y, % | +59% | 0% | +35% | 0% | +9% | +16.8% |
Novo Nordisk. FCF
Novo Nordisk. FCF, changes, %
Novo Nordisk. FCF, sum by quarters
Novo Nordisk (NVO) FCF US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
FCF | ? | 21 542 000 000 | 30 342 000 000 | -6 885 000 000 | 5 305 000 000 | 37 265 000 000 | 66 027 000 000 | |
Changes by years, y/y, % | +1% | +52% | -842% | -79% | +73% | |||
Changes by quarters, q/q, % | +41% | -123% | -177% | +602% |